Importantly, the majority of driver mutations in tumor suppressors (including TP53, KMT2D, ZNF750, etc.)had a tendency to locate in the trunks of phylogenetic trees, indicating that tumor suppressors are lost as relatively early events during ESCC development. The gene discussed is TP53; the disease is neoplasm.